PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.12%
Negative net income growth while MCHP stands at 5.78%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-0.97%
Negative yoy D&A while MCHP is 0.43%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
185.19%
Some yoy growth while MCHP is negative at -253.18%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-3.23%
Both cut yoy SBC, with MCHP at -9.53%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
49.40%
Less working capital growth vs. MCHP's 259.31%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
430.95%
AR growth while MCHP is negative at -387.03%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-371.43%
Negative yoy inventory while MCHP is 697.89%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
162.50%
AP growth well above MCHP's 151.54%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-82.87%
Negative yoy usage while MCHP is 341.92%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-517.39%
Both negative yoy, with MCHP at -34.33%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-8.03%
Negative yoy CFO while MCHP is 32.15%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-21.36%
Both yoy lines negative, with MCHP at -37.84%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
21.36%
Less M&A spending yoy vs. MCHP's 100.00%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-33.10%
Both yoy lines negative, with MCHP at -60.97%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
15.29%
Below 50% of MCHP's 72.05%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
68.13%
We have some outflow growth while MCHP is negative at -21.73%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-28.20%
We reduce yoy invests while MCHP stands at 15.30%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
105.88%
Issuance growth of 105.88% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-4.18%
We cut yoy buybacks while MCHP is 100.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.